Both in Biotechnology
BioCryst Pharmaceuticals vs Novavax
Over the past year BCRX returned +15.7% and NVAX returned +20.0%; their daily moves had a correlation of 0.14.
BCRX +15.7% NVAX +20.0%Growth of $1, one year, split-adjusted
| Metric | BCRX | NVAX |
|---|---|---|
| Price | $8.47 | $10.08 |
| Market cap | $2.16B | $1.66B |
| Today | −0.59% | −3.72% |
| 1 month | +4.3% | −4.9% |
| 6 months | −7.8% | +25.4% |
| Year to date | +8.6% | +50.0% |
| 1 year | +15.9% | +20.3% |
| Revenue growth (YoY) | +33.6% | −76.3% |
| Gross margin | 98.2% | 74.9% |
| Net margin | 35.9% | −94.2% |
| P/E (TTM) | — | — |
| Price / sales | 2.3× | 4.0× |
| Net cash | -$471.6M | $422.0M |
| Dividend yield | — | — |
| Volatility (60d) | 45.1% | 79.8% |
| Short % of float | 10.9% | 30.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).